Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generics
Pharma
Sandoz ponies up $265M to settle lingering price-fixing case
Sandoz will shell out $265 million to settle long-running price fixing claims it inherited from its former parent Novartis.
Fraiser Kansteiner
Feb 29, 2024 10:49am
Noumed Pharma breaks ground on $65M manufacturing plant
Feb 27, 2024 8:10am
Teva reports revenue increase, says it will sell API business
Jan 31, 2024 11:11am
Bora buys out generics manufacturer Upsher-Smith for $210M
Jan 17, 2024 10:55am
GSK, Amneal and Kaleo walk back patents after FTC's challenge
Dec 21, 2023 11:08am
Amid ADHD med shortage, AAM spotlights government restrictions
Nov 20, 2023 11:29am